Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Acta Orthopaedica Belgica|February 10, 2011
Extra-skeletal Ewing's sarcoma in adults: presentation of two casesSamuel M Lipski, Katia Cermak, Felix Shumelinsky, et al.
Anti-Cancer Drugs|November 1, 2006
Imatinib mesylate in a patient with metastatic disease originating from a dermatofibrosarcoma protuberans of the scalpBernd Kasper, Dominique Lossignol, Thierry Gil, et al.
Immunotherapy|November 24, 2015
Checkpoint inhibitors in bladder and renal cancers: results and perspectivesFouad Aoun, Hampig R Kourie, Spyridon Sideris, et al.
Annales D'Endocrinologie|April 12, 2016
Efficacy and safety of mitotane in the treatment of adrenocortical carcinoma: A retrospective study in 34 Belgian patientsDominique Maiter, Marie Bex, Laurent Vroonen, et al.
Annals of Nuclear Medicine|October 7, 2019
Evaluation of PSMA expression changes on PET/CT before and after initiation of novel antiandrogen drugs (enzalutamide or abiraterone) in metastatic castration-resistant prostate cancer patientsNicolas Plouznikoff, Carlos Artigas, Spyridon Sideris, et al.
Molecular and Clinical Oncology|June 11, 2016
Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancerSpyridon Sideris, Fouad Aoun, Marc Zanaty, et al.
The International Journal of Biochemistry & Cell Biology|June 5, 2007
Molecular targeted therapies in breast cancer: where are we now?Christian Widakowich, Evandro de Azambuja, Thierry Gil, et al.
Current Medical Research and Opinion|May 24, 2007
A phase I clinical and pharmacokinetic study of tipifarnib in combination with docetaxel in patients with advanced solid malignanciesAhmad Awada, Steven Zhang, Thierry Gil, et al.
Investigational New Drugs|October 29, 2008
Pemetrexed combined with paclitaxel: a dose-finding study evaluating three schedules in solid tumorsAxel-R Hanauske, Herlinde Dumez, Martine Piccart, et al.
Archives of Gynecology and Obstetrics|February 15, 2008
Oxaliplatin/5fluorouracil-based chemotherapy was active and well tolerated in heavily pretreated patients with ovarian carcinomaDaniela D Rosa, Ahmad Awada, Max S Mano, et al.
Pageof 5